Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.
about
Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitorEfflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureusAntimicrobial resistance: the example of Staphylococcus aureusMolecular properties of bacterial multidrug transportersEfflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatisA new two-component regulatory system involved in adhesion, autolysis, and extracellular proteolytic activity of Staphylococcus aureusMicrobial resistance: novel screens for a contemporary problem.NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomesEffect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporterMutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC.MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureusGenomewide screening for novel genetic variations associated with ciprofloxacin resistance in Bacillus anthracis.Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.Efflux pump-mediated quinolone resistance in Staphylococcus aureus strains wild type for gyrA, gyrB, grlA, and norA.Growth in the presence of salicylate increases fluoroquinolone resistance in Staphylococcus aureus.Introduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid integration.Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin.Mechanisms and frequency of resistance to premafloxacin in Staphylococcus aureus: novel mutations suggest novel drug-target interactionsMechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus.Expression of the multidrug resistance transporter NorA from Staphylococcus aureus is modified by a two-component regulatory system.A mutation in the 5' untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus.High-frequency transposition for determining antibacterial mode of action.Mechanisms of action and resistance of older and newer fluoroquinolones.Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteriaBactericidal activities of BMS-284756, a novel Des-F(6)-quinolone, against Staphylococcus aureus strains with topoisomerase mutations.Expression of multidrug resistance efflux pump gene norA is iron responsive in Staphylococcus aureus.Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone.DX-619, a novel des-fluoro(6) quinolone manifesting low frequency of selection of resistant Staphylococcus aureus mutants: quinolone resistance beyond modification of type II topoisomerases.LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureusMinimizing potential resistance: the molecular view--a comment on Courvalin and Trieu-Cuot.Glucose starvation-induced dispersal of Pseudomonas aeruginosa biofilms is cAMP and energy dependentGrepafloxacin: an overview of antibacterial activity, pharmacokinetics, clinical efficacy and safety.Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteriaAntimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methicillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome.Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureusActivity of and resistance to moxifloxacin in Staphylococcus aureus.Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistanceCharacterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus.Native efflux pumps contribute resistance to antimicrobials of skin and the ability of Staphylococcus aureus to colonize skin
P2860
Q24650801-832E83D6-9C8C-4840-AF7E-A432C37515CDQ24673074-EDB14046-5473-4CEE-BC36-27D410884F17Q24676363-971D3804-02D0-4E67-9748-FFAF0647C4BCQ28139376-CBA233F5-68A0-46FF-88D9-DF3D3338732CQ28378761-A63A729A-AE51-44E4-8E06-F1D1E1A754C4Q28485591-DD493A09-1B08-4D02-A208-C99E0BDCCAACQ30811045-EF32B7EB-3C65-42D0-BB8D-323B61AF7E37Q33183378-F15DA900-0CDB-4115-AD3F-2110D2659E72Q33555822-10B05F1D-37D0-4B35-9DE4-112CBDC4A517Q33690598-C1204503-23FC-465F-9881-015BC6554E1AQ33695982-B00700F3-EA97-45DC-A7D2-E5BDD3313D98Q33716692-F959A962-7B80-4521-88C7-6A706F454734Q33962831-47A1C581-15C4-46C7-8311-E00607A7739BQ33976061-0E5FC694-3001-4024-86D1-B30A6B5E0135Q33976079-B709B435-5B0E-41D5-BC46-31EF9FA85339Q33976799-CB4C90AD-4557-4276-973A-0D4B7DD8A6DFQ33977640-6ECB12A0-7BB8-4DB0-A1C2-2B7E83AAAC18Q33979593-5180081C-3B16-496C-A4C8-1092C3F863D8Q33980991-4E4CC104-3D93-47B3-954D-9707C848B83EQ33983092-1068C213-7858-4EC6-AD65-CCEB32F54128Q33993653-D5654C04-C2CB-4731-8F14-B5EBCE2E7982Q33995944-F65C9E3D-EC8B-4ED0-880B-05120E3AF4BCQ34011008-86FB2E68-C5FA-424C-9D3D-3A9AD2457062Q34030757-811A7ABD-950B-44F9-AB43-21659CCEE96DQ34035762-DC42696C-D275-4F89-A6D1-447BCC28B1A0Q34104362-13DC4DEA-9189-413F-9882-5A4B59D7CB09Q34135493-E151C0CA-B482-49D8-AF74-1823EEEBB04FQ34142238-245B0E24-EAC7-48E5-90D0-E17D7283F21BQ34228402-ABBDB747-1F11-4E38-B0AC-0C7A12925445Q34309539-56725651-0147-409B-98A9-5C2976023F57Q34347870-DE1289A3-0752-4C4F-A309-85ECD3F0ECC5Q34384606-B2F72605-3D87-4CB4-97C7-C9717364C42DQ34558942-30B097DA-6E4B-4C1C-AEC1-ABF4B103746FQ34647294-820E6EBE-F6DB-4D42-BEDF-A00F35251BDEQ34719378-4474FC98-F58C-4410-BC6C-AB3F86D45965Q34725095-64279AE0-3C0B-4110-BCA2-3AE8CAE58BD8Q34885313-1C8F7E7C-EFD9-4D74-93B1-E9C1872FFD32Q34927172-179AC0FC-DA96-4E16-8AA5-EA5F0ABBEEC0Q34977654-CE38435B-E7EC-4301-8D99-68D28819BB9BQ35054553-0B22DF99-E1E7-46CB-8274-66B87A6CD762
P2860
Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Quinolone resistance mediated ...... phylococcus aureus chromosome.
@ast
Quinolone resistance mediated ...... phylococcus aureus chromosome.
@en
type
label
Quinolone resistance mediated ...... phylococcus aureus chromosome.
@ast
Quinolone resistance mediated ...... phylococcus aureus chromosome.
@en
prefLabel
Quinolone resistance mediated ...... phylococcus aureus chromosome.
@ast
Quinolone resistance mediated ...... phylococcus aureus chromosome.
@en
P2093
P2860
P356
P1476
Quinolone resistance mediated ...... phylococcus aureus chromosome.
@en
P2093
P2860
P304
P356
10.1128/AAC.38.6.1345
P407
P577
1994-06-01T00:00:00Z